ruthenium has been researched along with bathophenanthroline in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Carlsson-Skwirut, C; Ernster, L | 1 |
Amouri, H; Caspar, R; Cordier, C; Gruselle, M; Guyard-Duhayon, C; Le Floch, P; Waern, JB | 1 |
Bannwarth, W; Claussnitzer, I; Gerrits, M; Uzagare, MC | 1 |
Ji, Z; Natu, G; Wu, Y | 1 |
Dvořák, Z; Štarha, P; Trávníček, Z; Vančo, J | 1 |
Brabec, V; Kasparkova, J; Kostrhunova, H; Novohradsky, V; Pracharova, J; Štarha, P; Trávníček, Z | 1 |
Babak, MV; Bezzubov, SI; Gushchin, AL; Hanif, M; Kajjout, M; Le Faouder, P; Poizat, O; Rolando, C; Trivelli, X; Venkatesan, G; Vezin, H | 1 |
Bonizzoni, M; Brown, SR; Cameron, CG; DeRegnaucourt, AR; Gray, JL; Hall, JF; Kim, Y; Lamb, RW; McFarland, SA; Oladipupo, OE; Papish, ET; Petersen, CM; Qu, F; Shrestha, AB; Thompson, MK; Ward, NA; Webster, CE; Xu, Y | 1 |
8 other study(ies) available for ruthenium and bathophenanthroline
Article | Year |
---|---|
Bathophenanthroline-ruthenium chelate, a fluorescent inhibitor of F1-ATPase.
Topics: Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cattle; Chelating Agents; Mitochondria, Heart; Phenanthrolines; Proton-Translocating ATPases; Ruthenium; Spectrometry, Fluorescence | 1982 |
A new family of mono- and dicarboxylic ruthenium complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): synthesis, solution behavior, and X-ray molecular structure of trans-[Ru(DIP)2(MeOH)2][OTf]2.
Topics: Crystallography, X-Ray; Dicarboxylic Acids; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Organometallic Compounds; Phenanthrolines; Ruthenium; Sensitivity and Specificity; Solutions; Stereoisomerism | 2006 |
Site specific chemoselective labelling of proteins with robust and highly sensitive Ru(II) bathophenanthroline complexes.
Topics: Molecular Structure; Phenanthrolines; Proteins; Ruthenium | 2012 |
Cyclometalated ruthenium sensitizers bearing a triphenylamino group for p-type NiO dye-sensitized solar cells.
Topics: 2,2'-Dipyridyl; Coloring Agents; Coordination Complexes; Nickel; Phenanthrolines; Ruthenium; Solar Energy | 2013 |
Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand.
Topics: Cell Proliferation; Coordination Complexes; Dichloroacetic Acid; Drug Liberation; Female; Humans; Ligands; Osmium; Ovarian Neoplasms; Phenanthrolines; Ruthenium | 2018 |
Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Osmium; Phenanthrolines; Ruthenium; Triple Negative Breast Neoplasms | 2018 |
Heteroleptic Ruthenium(II) Complexes with Bathophenanthroline and Bathophenanthroline Disulfonate Disodium Salt as Fluorescent Dyes for In-Gel Protein Staining.
Topics: Cell Line, Tumor; Coordination Complexes; Electrophoresis, Polyacrylamide Gel; Fluorescent Dyes; Humans; Phenanthrolines; Proteins; Ruthenium; Staining and Labeling | 2020 |
Light-responsive and Protic Ruthenium Compounds Bearing Bathophenanthroline and Dihydroxybipyridine Ligands Achieve Nanomolar Toxicity towards Breast Cancer Cells.
Topics: Breast Neoplasms; Female; Humans; Ligands; Phenanthrolines; Ruthenium; Ruthenium Compounds | 2022 |